Revistas
Revista:
DIAGNOSIS
ISSN:
2194-802X
Año:
2023
Vol.:
10
N°:
3
Págs.:
281 - 297
Objectives: Remote self-collected capillary blood samples have been proposed as alternative to venous blood samples as an aid in telemedicine. The aim of this work is to compare the preanalytical and analytical performance of these two types of samples and to study the stability of common measurands in capillary blood.
Methods: Capillary and venous blood samples were collected in parallel from 296 patients in serum tubes to analyze 22 common biochemistry magnitudes after centrifugation and in EDTA tubes to analyze 15 hematologic magnitudes. Quality of the preanalytical process was assessed applying the model of quality indicator. 24 h stability at room temperature was studied by obtaining paired capillary samples. A questionnaire of assessment was conducted.
Results: Mean hemolysis index was higher in capillary samples compared to venous blood samples (p<0.001). Regression analysis and difference analysis showed no bias for all studied biochemistry parameters and hematologic parameters, except mean corpuscular volume (MCV), between capillary and venous blood samples. Regarding sample stability, percentage deviation was higher than the corresponding minimum analytical performance specification for ferritin, vitamin D, hematocrit, MCV, mean corpuscular hemoglobin concentration, platelets distribution wide, mean platelet volume and basophils. Finger pricking was perceived as less painful (p<0.05) than venipuncture in participants who undergo more than one blood test per year.
Conclusions: Capillary blood can be used as an alternative to venous blood for the studied parameters in automated common clinical analyzers. Cautious should be taken if samples are not analyzed within 24 h from the collection.
Revista:
CLINICA CHIMICA ACTA
ISSN:
0009-8981
Año:
2023
Vol.:
548
Págs.:
117471
Introduction: Multiple sclerosis (MS) is the most frequent demyelinating disease of the central nervous system. Although there is currently no definite cure for MS, new therapies have recently been developed based on a continuous search for new biomarkers. Development: MS diagnosis relies on the integration of clinical, imaging and laboratory findings as there is still no single pathognomonic clinical feature or diagnostic laboratory biomarker. The most commonly laboratory test used is the presence of immunoglobulin G oligoclonal bands (OCB) in cerebrospinal fluid of MS patients. This test is now included in the 2017 McDonald criteria as a biomarker of dissemination in time. Nevertheless, there are other biomarkers currently in use such as kappa free light chain, which has shown higher sensitivity and specificity for MS diagnosis than OCB. In addition, other potential laboratory tests involved in neuronal damage, demyelination and/or inflammation could be used for detecting MS.Conclusions: CSF and serum biomarkers have been reviewed for their use in MS diagnosis and prognosis to stablish an accurate and prompt MS diagnosis, crucial to implement an adequate treatment and to optimize clinical outcomes over time.
Revista:
CLINICA CHIMICA ACTA
ISSN:
0009-8981
Año:
2023
Vol.:
548
Págs.:
117502
Background and aims: Patients' response to treatment in differentiated thyroid cancer (DTC) is classified ac-cording to serum thyroglobulin concentrations (Tg), usually using the American Thyroid Association guidelines and considering potential interfering anti-thyroglobulin antibodies (Ab-Tg). We aim to evaluate the clinical implications of changing Tg and Ab-Tg quantification method. Material and methods: Tg and Ab-Tg were quantified in 82 serum samples (60 from DTC patients) by Elecsys and Access immunoassays. Results: Elecsys immunoassay rendered higher values of Tg than Access: mean bias 5.03 ng/mL (95%CI:-14.14-24.21). In DTC patients, there was an almost perfect agreement for response classification (kappa index = 0.833). Discrepancies appeared in patients with undetermined response, with a more tendency to subclassifi-cation with Access. Ab-Tg showed a poor correlation (r = 0.5394). When Elecsys cut-off was reduced to 43 IU/ mL, agreement for positive/negative classification improved from a kappa index of 0.607 to 0.650. Prospective study with personalized follow-up showed that only 6.3% of Tg results required an analytical confirmation, being confirmed 93% of them. Conclusions: Despite the biases observed, clinical impact of an analytical change is minimal in patients' man-agement. However, cautious and personalized follow-up period after the change is still mandatory, especially in patients with Tg levels between 0.2 and 1 ng/mL.
Revista:
ADVANCES IN LABORATORY MEDICINE / AVANCES EN MEDICINA DE LABORATORIO
ISSN:
2628-491X
Año:
2022
Vol.:
3
N°:
4
Págs.:
317 - 318
Revista:
BIOMOLECULES
ISSN:
2218-273X
Año:
2020
Vol.:
10
N°:
12
Págs.:
1697
Hypoandrogenemia, a frequent finding in men with obesity, is defined by low concentrations of serum testosterone. Although immunoassay (IA) is the most used method for the determination of this steroid in clinical practice, liquid chromatography-mass spectrometry (LC-MS/MS) is considered a more reliable method. In this study, we aimed to compare IA versus LC-MS/MS measurement for the diagnosis of hypoandrogenemia in a cohort of 273 nondiabetic young obese men. Mean total testosterone (TT) levels were 3.20 ± 1.24 ng/mL for IA and 3.78 ± 1.4 ng/mL for LC-MS/MS. 53.7% and 26.3% of patients were classified as presenting hypoandrogenemia with IA and LC-MS/MS, respectively. Considering LC-MS/MS as the reference method, sensitivity and specificity of IA were 91.4% (95% CI 82.3-96.8) and 61.1% (95% CI 54.0-67.8), respectively. IA presented an AUC of 0.879 (95% CI 0.83-0.928). Multivariate regression analysis indicated that sex hormone-binding globulin (SHBG) concentrations (p = 0.002) and insulin resistance (p = 0.008) were factors associated with discrepant IA values. In conclusion, the determination of TT by IA in nondiabetic young men with obesity yields lower concentrations of TT than LC-MS/MS, resulting in an equivocal increased diagnosis of hypoandrogenemia, which could lead to inaccurate diagnosis and unnecessary treatment.
Capítulos de libros
Autores:
Jordano-Montilla, A.; Cárdenas-Gámez, R.; García-Ruano, A. B.; et al.
Libro:
Avances de Investigación en salud y bienestar: cambiando la realidad de los pacientes
Lugar de Edición:
Almería
Editorial:
ASUNIVEP
Año:
2020
Págs.:
403 - 409
Libro:
Conocimientos, investigación y prácticas en el campo de la salud: innovación y cambio en competencias profesionales
Lugar de Edición:
Almería
Editorial:
ASUNIVEP
Año:
2020
Págs.:
329 - 337
Autores:
Aguilar-Castillo, M. J.; Maroto-García, J; Jordano-Montilla, A.; et al.
Libro:
Conocimientos, investigación y prácticas en el campo de la salud: innovación y cambio en competencias profesionales
Lugar de Edición:
Almería
Editorial:
ASUNIVEP
Año:
2020
Págs.:
317 - 322
Libro:
Avances de investigación en salud y bienestar: cambiando la realidad de los pacientes
Lugar de Edición:
Almería
Editorial:
ASUNIVEP
Año:
2020
Págs.:
419 - 425
Autores:
Cárdenas-Gámez, R.; García-Ruano, A. B.; Castro-Vega, I. M; et al.
Libro:
Salud, alimentación y sexualidad en el ciclo vital: nuevos horizontes para la intervención
Editorial:
ASUNIVEP
Año:
2020
Págs.:
93 - 98
Autores:
García-Ruano, A. B.; Castro-Vega, I. M.; Aguilar-Castillo, M. J.; et al.
Libro:
Conocimientos, investigación y prácticas en el campo de la salud: innovación y cambio en competencias profesionales
Lugar de Edición:
Almería
Editorial:
ASUNIVEP
Año:
2020
Págs.:
293 - 297